Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Death, Sudden, Cardiac

• Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
• Micophenolate Mofetil Versus Azathioprine in Myocarditis
• Monitoring of Arrhythmias in Patients Treated With Antipsychotics
• Personalised Risk scOre For Implantation of Defibrillators in Patients With Reduced LVEF≤35% and a Low Risk for Sudden Cardiac Death
• Personalised Risk scOre For Implantation of Defibrillators in Patients With Preserved LVEF>35% and a High Risk for Sudden Cardiac Death
• Epinephrine Dose: Optimal Versus Standard Evaluation Trial
• Exploring Mechanisms and Morphology of QT Interval Prolongation
• Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death
• Domperidone and Risk of Sudden Cardiac Death
• The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon
• An Observational Study to Assess the Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Users of Proton Pump Inhibitors, and Users of Metoclopramide
• Heart Rate Response to Regadenoson and Sudden Cardiac Death
• Sodium Bicarbonate in Cardiopulmonary Resuscitation
• Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
• Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction
• Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone
• In-hospital Cardiac Arrest - Dynamics and State Transitions
• Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
• Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker
• Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death
• Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
• Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients
• OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction
• Protective Effect of EPA on Cardiovascular Events
• Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
• Antiarrhythmics Versus Implantable Defibrillators (AVID)
• Cardiac Arrhythmia Suppression Trial (CAST)
• Diuretics, Hypertension, and Arrhythmias Clinical Trial
• Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
• Beta-Blocker Heart Attack Trial (BHAT)
• Multicenter Unsustained Tachycardia Trial (MUSTT)